Cross Country Healthcare (NASDAQ:CCRN) Given “Market Perform” Rating at Barrington Research

Barrington Research reaffirmed their market perform rating on shares of Cross Country Healthcare (NASDAQ:CCRNFree Report) in a report released on Tuesday, MarketBeat.com reports.

Several other equities analysts also recently commented on the company. William Blair downgraded Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 4th. Benchmark downgraded shares of Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 4th. Finally, Truist Financial lifted their price objective on shares of Cross Country Healthcare from $15.00 to $18.61 and gave the company a “hold” rating in a report on Thursday, December 5th. Four analysts have rated the stock with a hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $18.54.

Check Out Our Latest Research Report on CCRN

Cross Country Healthcare Price Performance

Shares of NASDAQ:CCRN opened at $18.07 on Tuesday. The firm has a market capitalization of $594.81 million, a PE ratio of -361.40, a price-to-earnings-growth ratio of 3.45 and a beta of 0.61. The business has a 50 day simple moving average of $12.16 and a two-hundred day simple moving average of $13.76. Cross Country Healthcare has a 1 year low of $9.58 and a 1 year high of $23.64.

Institutional Trading of Cross Country Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the company. Truvestments Capital LLC bought a new position in Cross Country Healthcare during the 3rd quarter worth about $39,000. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Cross Country Healthcare during the third quarter valued at approximately $49,000. nVerses Capital LLC bought a new position in Cross Country Healthcare in the second quarter worth approximately $50,000. Point72 DIFC Ltd purchased a new stake in Cross Country Healthcare during the third quarter worth $52,000. Finally, Gladius Capital Management LP lifted its holdings in Cross Country Healthcare by 83.4% during the third quarter. Gladius Capital Management LP now owns 3,985 shares of the business services provider’s stock worth $54,000 after buying an additional 1,812 shares during the period. 96.03% of the stock is currently owned by institutional investors.

Cross Country Healthcare Company Profile

(Get Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Further Reading

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.